Research

Hormonal

Sibutramine combined with microcrystalline cellulose (Reduxin) produces clinically significant weight loss (average 20.0 kg over 12 months) and reduces waist circumference in patients with alimentary obesity and comorbidities.

For patients with obesity and comorbidities, a 12-month course of sibutramine (Reduxin) under medical supervision can result in significant weight loss (approx. 20kg) and waist reduction. Heart rate does not significantly increase with proper monitoring.

ModerateSupportsMEDIUM confidence
В группе двенадцатимесячного лечебного курса снижение ИМТ было в 2,12 раза более значимым и составило 7,2±3,07 кг/м2 (20,0±8,62 кг). Среднее снижение окружности талии за 3, 6, 12 месяцев терапии составило 6,3±4,31 см, 10,6±6,30 см, 16,0±8,94 см соответственно.
И. И. Дедов et al. · Obesity and metabolism · 2016

Why this rating

Large observational study (n=69,810) but non-randomized and industry-sponsored.

Source

The strategy of obesity management: the results of All-Russian observational program “Primavera”

И. И. Дедов et al. · Obesity and metabolism · 2016

DOI 10.14341/omet2016136-44

cohort · n=98774Cited 22×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →